Temasek Holdings’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-566,650
Closed -$703K – 143
2024
Q3
$703K Hold
566,650
– – ﹤0.01% 119
2024
Q2
$946K Hold
566,650
– – ﹤0.01% 88
2024
Q1
$1.05M Hold
566,650
– – 0.01% 98
2023
Q4
$1.08M Hold
566,650
– – 0.01% 95
2023
Q3
$748K Hold
566,650
– – ﹤0.01% 78
2023
Q2
$1.69M Hold
566,650
– – 0.01% 63
2023
Q1
$1.96M Hold
566,650
– – 0.01% 62
2022
Q4
$2.37M Hold
566,650
– – 0.01% 62
2022
Q3
$2.27M Hold
566,650
– – 0.01% 70
2022
Q2
$6.4M Hold
566,650
– – 0.04% 74
2022
Q1
$9.2M Hold
566,650
– – 0.04% 82
2021
Q4
$26.9M Hold
566,650
– – 0.1% 65
2021
Q3
$41.1M Sell
566,650
-39,420
-7% -$2.85M 0.14% 59
2021
Q2
$50.9M Buy
+606,070
New +$40M 0.17% 55

Other funds holding NBP

Temasek Holdings's NBP Position: Q4 2024 in Review

Temasek Holdings sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q4 2024, closing a stake of 566,650 shares — an estimated $703K sold.

Temasek Holdings first reported a position in NBP in Q2 2021 and held it in 14 quarters. The position peaked at $50.9M in Q2 2021. 28 funds tracked by Wall St. Rank hold NBP as of Q4 2024.

  • Temasek Holdings reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q4 2024 after selling out during the quarter.
  • Temasek Holdings sold 566,650 NovaBridge Biosciences American Depositary Shares shares in Q4 2024, an estimated $703K.
  • Temasek Holdings first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 14 quarters.
  • Temasek Holdings's NovaBridge Biosciences American Depositary Shares position peaked at $50.9M in Q2 2021.
  • 28 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q4 2024.

Based on Temasek Holdings's 13F filing for Q4 2024, filed 14 Feb 2025.